Trials / Completed
CompletedNCT00597051
Study of 3 Doses of ARD-0403 in Testosterone Deficient Men
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Multi-Centre Study of the Pharmacokinetics and Tolerability of 3 Different Doses of ARD-0403 in Testosterone Deficient Men
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Ardana Bioscience Ltd · Industry
- Sex
- Male
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine which dose, if any, results in testosterone levels within the normal range for men.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ARD-0403 |
Timeline
- Start date
- 2005-10-01
- Primary completion
- 2006-02-01
- Completion
- 2006-02-01
- First posted
- 2008-01-17
- Last updated
- 2008-01-17
Locations
1 site across 1 country: Belarus
Source: ClinicalTrials.gov record NCT00597051. Inclusion in this directory is not an endorsement.